← 홈

Antibody · 림프종 · PD-1 / PD-L1

3개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3개
AntibodyBHotMerckvedotin plus pembrolizumab …Phase 2

PD-1 Blocking Antibody (Pembrolizumab, Pembrolizumab (PD-1 Blocking Antibody))

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · PD-1

#PD-1#Antibody#Phase2#인기#항체+5
효능 ORR 75%임상시험 151상태 ACTIVE
AntibodystaleRochePhase 2

Anti-PD-1 Antibody Plus Chidamide and Rituximab (Anti-PD-1 Antibody Plus Chidamide and Rituximab)

Relapsed or Refractory DLBCL · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleInnoventPhase 2

PD-1 inhibitor (Sintilimab, Sintilimab (PD-1 inhibitor))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING